165 related articles for article (PubMed ID: 32729015)
1. Patients with More Severe IBD Get Clostridioides difficile Rather than Clostridioides difficile Increasing the Severity of IBD.
Varma S; Faye AS; Kannan A; Lawlor G; Verma A; Axelrad J; Freedberg DE
Dig Dis Sci; 2021 Sep; 66(9):3113-3123. PubMed ID: 32729015
[TBL] [Abstract][Full Text] [Related]
2. Recent trends and risk factors associated with Clostridioides difficile infections in hospitalized patients with inflammatory bowel disease.
Spartz EJ; DeDecker LC; Fansiwala KM; Noorian S; Roney AR; Hakimian S; Sauk JS; Chen PH; Limketkai BN
Aliment Pharmacol Ther; 2024 Jan; 59(1):89-99. PubMed ID: 37873878
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease.
Tariq R; Disbrow MB; Dibaise JK; Orenstein R; Saha S; Solanky D; Loftus EV; Pardi DS; Khanna S
Inflamm Bowel Dis; 2020 Aug; 26(9):1415-1420. PubMed ID: 31821444
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes for Clostridioides difficile associated diarrhea in inflammatory bowel disease patients versus non-IBD population: A retrospective cohort study.
Drozdinsky G; Atamna A; Banai H; Ben-Zvi H; Bishara J; Eliakim-Raz N
Medicine (Baltimore); 2023 Feb; 102(6):e32812. PubMed ID: 36820599
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.
Nitzan O; Elias M; Chazan B; Raz R; Saliba W
World J Gastroenterol; 2013 Nov; 19(43):7577-85. PubMed ID: 24282348
[TBL] [Abstract][Full Text] [Related]
6. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
Luo Y; Tixier EN; Grinspan AM
Dig Dis Sci; 2020 Dec; 65(12):3647-3651. PubMed ID: 32078714
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
Gupta A; Wash C; Wu Y; Sorrentino D; Nguyen VQ
Dig Dis Sci; 2021 Feb; 66(2):547-553. PubMed ID: 32207033
[TBL] [Abstract][Full Text] [Related]
8. [
Lee MR; Kim ES
Korean J Gastroenterol; 2022 Aug; 80(2):66-71. PubMed ID: 36004633
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and Risk Factors of Clostridium difficile Infection Among Patients Hospitalized for a Flare of Inflammatory Bowel Disease in King Abdulaziz University Hospital.
Samman AA; Alfares M; Bajabur RA; Alnefaie RO; Alwadai LS; Murad WW; Dahal BM
Cureus; 2023 Nov; 15(11):e48451. PubMed ID: 38074066
[TBL] [Abstract][Full Text] [Related]
10. Anti-TNF containing regimens may be associated with increased risk of Clostridioides difficile infection in patients with underlying inflammatory bowel disease.
Gholam-Mostafaei FS; Yadegar A; Aghdaei HA; Azimirad M; Daryani NE; Zali MR
Curr Res Transl Med; 2020 Aug; 68(3):125-130. PubMed ID: 32414632
[TBL] [Abstract][Full Text] [Related]
11. Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease.
Abdehagh M; Azimirad M; Houri H; Nadalian B; Azimirad F; Olfatifar M; Nasir Shoeibi OK; Yadegar A; Shahrokh S; Mahdavi Roshan M; Asadzadeh Aghdaei H; Zali MR
BMC Infect Dis; 2021 Oct; 21(1):1103. PubMed ID: 34702217
[TBL] [Abstract][Full Text] [Related]
12. Clostridium difficile infection in acute flares of inflammatory bowel disease: A prospective study.
Sokol H; Lalande V; Landman C; Bourrier A; Nion-Larmurier I; Rajca S; Kirchgesner J; Seksik P; Cosnes J; Barbut F; Beaugerie L
Dig Liver Dis; 2017 Jun; 49(6):643-646. PubMed ID: 28215602
[TBL] [Abstract][Full Text] [Related]
13. Impact of superimposed Clostridium difficile infection in Crohn's or ulcerative colitis flares in the outpatient setting.
Garcia PG; Chebli LA; da Rocha Ribeiro TC; Gaburri PD; de Lima Pace FH; Barbosa KVBD; Costa LA; de Almeida Cruz W; de Assis IC; Moraes BRM; Zanini A; Chebli JMF
Int J Colorectal Dis; 2018 Sep; 33(9):1285-1294. PubMed ID: 29926235
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease.
Dalal RS; Allegretti JR
Curr Opin Gastroenterol; 2021 Jul; 37(4):336-343. PubMed ID: 33654015
[TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile in inflammatory bowel disease.
Alhobayb T; Ciorba MA
Curr Opin Gastroenterol; 2023 Jul; 39(4):257-262. PubMed ID: 37265220
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile infection in hospitalized patients with inflammatory bowel disease: Prevalence, risk factors, and prognosis.
Maharshak N; Barzilay I; Zinger H; Hod K; Dotan I
Medicine (Baltimore); 2018 Feb; 97(5):e9772. PubMed ID: 29384868
[TBL] [Abstract][Full Text] [Related]
17. Non-Clostridium difficile Bacterial Infections Are Rare in Patients With Flares of Inflammatory Bowel Disease.
Hanada Y; Khanna S; Loftus EV; Raffals LE; Pardi DS
Clin Gastroenterol Hepatol; 2018 Apr; 16(4):528-533. PubMed ID: 29037938
[TBL] [Abstract][Full Text] [Related]
18. Clostridioides difficile Infection in Children With Inflammatory Bowel Disease.
Chandrakumar A; Zohni H; El-Matary W
Inflamm Bowel Dis; 2020 Oct; 26(11):1700-1706. PubMed ID: 31765471
[TBL] [Abstract][Full Text] [Related]
19. Effect of clinical versus administrative data definitions on the epidemiology of C. difficile among hospitalized individuals with IBD: a population-based cohort study.
Shaffer SR; Nugent Z; Bernstein CN; Walkty A; Singh H
BMC Gastroenterol; 2022 Mar; 22(1):140. PubMed ID: 35346066
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology and clinical characteristics of Clostridioides difficile infection in patients with inflammatory bowel disease from a teaching hospital.
Li YM; Liao JZ; Jian ZJ; Li HL; Chen X; Liu QX; Liu PL; Wang ZQ; Liu X; Yan Q; Liu WE
J Clin Lab Anal; 2022 Dec; 36(12):e24773. PubMed ID: 36397282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
